Biocept
Biocept to Lay Off 35 Percent of Staff, Explore Strategic Alternatives
The company is hoping to preserve its cash runway and find a way to derive some value for its shareholders from its cerebrospinal fluid assay CNSide.
In Brief This Week: Biocept, Thermo Fisher, Biodesix, More
News items for the week of Nov. 21, 2022.
People in the News at Haystack Oncology, Alveo Technologies, Biofidelity, Biocept, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Nov. 14, 2022.
Earnings Roundup: HTG Molecular, T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen
The genomic and diagnostics firms posted quarterly financial results late this week.
In Brief This Week: Genetron, MDxHealth, Biocept, Beckman Coulter, Biocartis, Satio, More
News items for the week of Aug. 22, 2022.